Pharma IQ Members


Carcinogenicity, or a carcinogen, is any substance, radionuclide or radiation, that is an agent directly involved in causing cancer. This may be due to the ability to damage the genome or to the disruption of cellular metabolic processes. Several radioactive substances are considered carcinogens, but their carcinogenic activity is attributed to the radiation, for example gamma rays and alpha particles, which they emit. Carcinogenicity of radiation depends of the type of radiation, type of exposure, and penetration.

Pharma IQ

Dr. Timothy Robison, Pharmacology/Toxicology Reviewer at the US Food and Drug Administration/CDER, joins Helen Winsor from Pharma IQ, to share the latest insights into achieving successful characterisation of genotoxic impurities and accurate...

Contributor: Pharma IQ
Tue, 09/21/2010
Pharma IQ News

Pharma IQ has interviewed Dr. Timothy Robison, Pharmacology and Toxicity Reviewer at the US Food & Drug Administration (FDA) and CDER, in an exclusive podcast ahead of his presentations at the Genotoxicity & Carcinogenicity Testing...

Contributor: Pharma IQ News
Thu, 09/09/2010
Pharma IQ

Dr. Andrew Teasdale, Senior QA Executive at AstraZeneca, joins Helen Winsor from Pharma IQ, to discuss genotoxicity and carcinogenicity testing. He begins by summing up the challenges that exist with interpreting the regulatory guidelines, and...

Contributor: Pharma IQ
Sun, 08/08/2010